Neuro-Oncology Reviews

Volume 25 Number 16
31 August 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 16, 31 August

Bianconi A, Bonada M, Zeppa P, Colonna S, Tartara F, Melcarne A, Garbossa D, Cofano F.
How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores.
Cancers (Basel). 2023 Aug 16;15(16):4130
. doi: 10.3390/cancers15164130. PMID: 37627158. Review. ˍ

Eliyasi Dashtaki M, Moradi Z, Moradi Y, Asadi E, Ghasemi S.
Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis.
Curr Drug Targets. 2023 Aug 16
. doi: 10.2174/1389450124666230816114131. PMID: 37587807. Review, Meta-analysis˰ ˍ

Nafe R, Hattingen E.
The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review.
Biomedicines. 2023 Aug 16;11(8):2281
. doi: 10.3390/biomedicines11082281. PMID: 37626776. Review. ˍ

Schladerer SP, Otth M, Scheinemann K.
Quality criteria for pediatric oncology centers: A systematic literature review.
Cancer Med. 2023 Aug 16
. doi: 10.1002/cam4.6452. PMID: 37584279. Review. ˍ

Askari FS, Mohebbi A, Ning J, Kurozumi K, Wakimoto H.
Editorial: Recent advances in oncolytic virus therapy for brain tumors.
Front Cell Infect Microbiol. 2023 Aug 17;13:1271559
. doi: 10.3389/fcimb.2023.1271559. PMID: 37662010. Editorial. ˍ

Endersby R, Wainwright BJ, Gottardo NG.
Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors.
Front Oncol. 2023 Aug 17;13:1274465
. doi: 10.3389/fonc.2023.1274465. PMID: 37664044. Editorial. ˍ

Guarnera A, Romano A, Moltoni G, Ius T, Palizzi S, Romano A, Bagatto D, Minniti G, Bozzao A.
The Role of Advanced MRI Sequences in the Diagnosis and Follow-Up of Adult Brainstem Gliomas: A Neuroradiological Review.
Tomography. 2023 Aug 18;9(4):1526-1537
. doi: 10.3390/tomography9040122. PMID: 37624115. Review. ˍ

Hooper GW, Ansari S, Johnson JM, Ginat DT.
Advances in the Radiological Evaluation of and Theranostics for Glioblastoma.
Cancers (Basel). 2023 Aug 18;15(16):4162
. doi: 10.3390/cancers15164162. PMID: 37627190. Review. ˍ

Sahoo DK, Mishra S, Mohanty MN, Behera RK, Dhar SK.
Brain Tumor Detection using Deep Learning Approach.
Neurol India. 2023 Aug 18;71(4):647-654
. doi: 10.4103/0028-3886.383858. PMID: 37635491. Review. ˍ


Segar DJ, Bernstock JD, Rampersad S, Linda Bi W, Arnaout O, Friedman GK, Chiocca EA.
Intracranial stimulation for brain cancer-The case for implantable, intracranial tumor treating fields.
Neurooncol Adv. 2023 Aug 19;5(1):vdad100
. doi: 10.1093/noajnl/vdad100. PMID: 37706199. Review. ˍ

Tang F, Wang Y, Zeng Y, Xiao A, Tong A, Xu J.
Tumor-associated macrophage-related strategies for glioma immunotherapy.
NPJ Precis Oncol. 2023 Aug 19;7(1):78
. doi: 10.1038/s41698-023-00431-7. PMID: 37598273. Review. ˍ

Hasanzadeh A, Moghaddam HS, Shakiba M, Jalali AH, Firouznia K.
The Role of Multimodal Imaging in Differentiating Vasogenic from Infiltrative Edema: A Systematic Review.
Indian J Radiol Imaging. 2023 Aug 21;33(4):514-521. doi: 10.1055/s-0043-1772466. PMID: 37811185. Review.

Hu Y, Li Z, Zhang Y, Wu Y, Liu Z, Zeng J, Hao Z, Li J, Ren J, Yao M.
The Evolution of Tumor Microenvironment in Gliomas and Its Implication for Target Therapy.
Int J Biol Sci. 2023 Aug 21;19(13):4311-4326
. doi: 10.7150/ijbs.83531. PMID: 37705736. Review. ˍ

Huisman TAGM, Patel R, Kralik S, Desai NK, Meoded A, Chen K, Weiner HL, Curry DJ, Lequin M, Kranendonk M, Orman G, Jallo G.
Advances in Imaging Modalities for Pediatric Brain and Spinal Cord Tumors.
Pediatr Neurosurg. 2023 Aug 21
. doi: 10.1159/000531998? PMID: 37604135. Review. ˍ


Yuan Y, Su Y, Wu Y, Xue Y, Zhang Y, Zhang Y, Zheng M, Chang T, Qu Y, Zhao T.
Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis.
Front Oncol. 2023 Aug 21;13:1229905
. doi: 10.3389/fonc.2023.1229905. PMID: 37671057. Bibliometric analysis. ˍ

Bérard C, Truillet C, Larrat B, Dhermain F, Estève MA, Correard F, Novell A.
Anticancer drug delivery by focused ultrasound-mediated blood-brain/tumor barrier disruption for glioma therapy: From benchside to bedside.
Pharmacol Ther. 2023 Aug 22;250:108518
. doi: 10.1016/j.pharmthera.2023.108518. PMID: 37619931. Review˰ ˍ

Ismail M, Craig S, Ahmed R, de Blank P, Tiwari P.
Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors.
Diagnostics (Basel). 2023 Aug 22;13(17):2727
. doi: 10.3390/diagnostics13172727. PMID: 37685265. Review. ˍ

Lee J, Chen MM, Liu HL, Ucisik FE, Wintermark M, Kumar VA.
MR Perfusion Imaging for Gliomas.
Magn Reson Imaging Clin N Am. 2023 Aug 22, 2024;32(1):73-83. doi: 10.1016/j.mric.2023.07.003. PMID: 38007284. Review˰ ˍ


Wang XC, Tang YL, Liang XH.
Tumour follower cells: A novel driver of leader cells in collective invasion (Review).
Int J Oncol. 2023 Aug 22;63(4):115
. doi: 10.3892/ijo.2023.5563. PMID: 37615176. Review. ˍ

Ren CC, Xu B, Wang MS, He F, Chen JH, Liao L, Liang W.
Meta-analysis of the correlation between glioma prognosis and PD-1/PD-L1 expression.
Asian J Surg. 2023 Aug 23:S1015-9584(23)01225-3
. doi: 10.1016/j.asjsur.2023.08.057. PMID: 37625958. Meta-analysis. ˍ

Todeschi J, Dannhoff G, Chibbaro S, Segbedji F, Spatola G, Mallereau CH, Noel G, Schott R, Lhermitte B, Cebula H, Ganau M.
Second Cancer affecting the Central Nervous System: Systematic Literature Review Exploring the Link between Malignant Melanoma and Glioblastoma.
World Neurosurg. 2023 Aug 23:S1878-8750(23)01185-3. doi: 10.1016/j.wneu.2023.08.073. PMID: 37625631. Review˰ ˍ

Papadopoulou A, Kumar NS.
Prognostic Factors and Resectability Predictors in Insular Gliomas: A Systematic Review.
J Neurol Surg A Cent Eur Neurosurg. 2023 Aug 24
. doi: 10.1055/s-0043-1769128. PMID: 37619597. Review. ˍ

Skouras P, Markouli M, Kalamatianos T, Stranjalis G, Korkolopoulou P, Piperi C.
Advances on Liquid Biopsy Analysis for Glioma Diagnosis.
Biomedicines. 2023 Aug 24;11(9):2371
. doi: 10.3390/biomedicines11092371. PMID: 37760812. Review. ˍ

Sleurs C, Fletcher P, Mallucci C, Avula S, Ajithkumar T.
Neurocognitive Dysfunction After Treatment for Pediatric Brain Tumors: Subtype-Specific Findings and Proposal for Brain Network-Informed Evaluations.
Neurosci Bull. 2023 Aug 24
. doi: 10.1007/s12264-023-01096-9. PMID: 37615933. Review. ˍ

Veikutis V, Brazdziunas M, Keleras E, Basevicius A, Grib A, Skaudickas D, Lukosevicius S.
Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study.
Curr Oncol. 2023 Aug 24;30(9):7818-7835
. doi: 10.3390/curroncol30090568. PMID: 37754483. Review, Observational study. ˍ

Ahmed SK, Keole SR.
Proton Therapy in the Adolescent and Young Adult Population.
Cancers (Basel). 2023 Aug 25;15(17):4269
. doi: 10.3390/cancers15174269. PMID: 37686545. Review. ˍ

Bozzao A, Weber D, Crompton S, Braz G, Csaba D, Dhermain F, Finocchiaro G, Flannery T, Kramm C, Law I, Marucci G, Oliver K, Ostgathe C, Paterra R, Pesce G, Smits M, Soffietti R, Terkola R, Watts C, Costa A, Poortmans P.
European Cancer Organisation Essential Requirements for Quality Cancer Care: adult glioma.
J Cancer Policy. 2023 Aug 25:100438
. doi: 10.1016/j.jcpo.2023.100438. PMID: 37634617. Editorial˰ ˍ

De Pietro R, Zaccaro L, Marampon F, Tini P, De Felice F, Minniti G.
The evolving role of reirradiation in the management of recurrent brain tumors.
J Neurooncol. 2023 Aug 25
. doi: 10.1007/s11060-023-04407-2. PMID: 37624529. Review. ˍ

Qureshi HM, Tabor JK, Pickens K, Lei H, Vasandani S, Jalal MI, Vetsa S, Elsamadicy A, Marianayagam N, Theriault BC, Fulbright RK, Qin R, Yan J, Jin L, O'Brien J, Morales-Valero SF, Moliterno J.
Frailty and postoperative outcomes in brain tumor patients: a systematic review subdivided by tumor etiology.
J Neurooncol. 2023 Aug 25
. doi: 10.1007/s11060-023-04416-1. PMID: 37624530. Review. ˍ

Reddy R, Yan SC, Hasanpour Segherlou Z, Hosseini-Siyanaki MR, Poe J, Perez-Vega C, Chiocca EA, Lucke-Wold B.
Oncolytic viral therapy: a review and promising future directions.
J Neurosurg. 2023 Aug 25:1-9. doi: 10.3171/2023.6.JNS23243. PMID: 37877961. Review˰

Gonçalves TL, de Araújo LP, Pereira Ferrer V.
Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
Cytokine. 2023 Aug 26;170:156344
. doi: 10.1016/j.cyto.2023.156344. PMID: 37639844. Review˰ ˍ

Vaz-Salgado MA, Villamayor M, Albarrán V, Alía V, Sotoca P, Chamorro J, Rosero D, Barrill AM, Martín M, Fernandez E, Gutierrez JA, Rojas-Medina LM, Ley L.
Recurrent Glioblastoma: A Review of the Treatment Options.
Cancers (Basel). 2023 Aug 26;15(17):4279
. doi: 10.3390/cancers15174279. PMID: 37686553. Review. ˍ

Bagchi A, Dhanda SK, Dunphy P, Sioson E, Robinson GW.
Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
J Natl Compr Canc Netw. 2023 Aug 28:1-9
. doi: 10.6004/jnccn.2023.7024. PMID: 37643637. Review. ˍ

Tao JC, Yu D, Shao W, Zhou DR, Wang Y, Hou SQ, Deng K, Lin N.
Interactions between microglia and glioma in tumor microenvironment.
Front Oncol. 2023 Aug 28;13:1236268
. doi: 10.3389/fonc.2023.1236268. PMID: 37700840. Review. ˍ

Liu X, Zhao Z, Dai W, Liao K, Sun Q, Chen D, Pan X, Feng L, Ding Y, Wei S.
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma.
Cancers (Basel). 2023 Aug 29;15(17):4308
. doi: 10.3390/cancers15174308. PMID: 37686584. Review. ˍ

Patiño-García A, Alonso MM, Gállego Pérez-Larraya J.
Promises of oncolytic viral therapy for adult and children with brain glioma.
Curr Opin Oncol. 2023 Aug 29;35(6):529-535. doi: 10.1097/CCO.0000000000000995. PMID: 37820087. Review˰

Roque D, Cruz N, Ferreira HA, Reis CP, Matela N, Herculano-Carvalho M, Cascão R, Faria CC.
Nanoparticle-Based Treatment in Glioblastoma.
J Pers Med. 2023 Aug 29;13(9):1328
. doi: 10.3390/jpm13091328. PMID: 37763096. Review. ˍ

Ale Y, Nainwal N.
Progress and Challenges in the Diagnosis and Treatment of Brain Cancer Using Nanotechnology.
Mol Pharm. 2023 Aug 30
. doi: 10.1021/acs.molpharmaceut.3c00554. PMID: 37647568. Review˰ ˍ

de Ruiter Swain J, Michalopoulou E, Noch EK, Lukey MJ, Van Aelst L.
Metabolic partitioning in the brain and its hijacking by glioblastoma.
Genes Dev. 2023 Aug 30
. doi: 10.1101/gad.350693.123. PMID: 37648371. Review˰ ˍ

Perez Giraldo GS, Singer L, Cao T, Jamshidi P, Dixit K, Kontzialis M, Castellani R, Pytel P, Anadani N, Bevan CJ, Grebenciucova E, Balabanov R, Cohen BA, Graham EL.
Differential Diagnosis of Tumor-like Brain Lesions.
Neurol Clin Pract. 2023 Aug 30;13(5):e200182
. doi: 10.1212/CPJ.0000000000200182. PMID: 37664132. Review˰ ˍ

Pires HFO, da Silva PR, Dias AL, de Sousa Gomes C, de Sousa NF, Dos Santos AMF, Souza LRP, de Figueiredo Lima JL, Oliveira MCN, Felipe CFB, de Almeida RN, de Castro RD, da Silva Stiebbe Salvadori MG, Scotti MT, Scotti L.
Mechanisms Involved in the Therapeutic Effect of Cannabinoid Compounds on Gliomas: A Review with Experimental Approach.
Curr Protein Pept Sci. 2023 Aug 30
. doi: 10.2174/1389203724666230830125423. PMID: 37649287. Review˰ ˍ

Smolarska A, Pruszynska I, Wasylko W, Godlewska K, Markowska M, Rybak A, Botther J, Kucharzewska P, Nowakowska J, Szeliga J, Kubiak M, Gorczak M, Krol M.
Targeted therapies for glioblastoma treatment.
J Physiol Pharmacol. 2023 Aug 30;74(3)
. doi: 10.26402/jpp.2023.3.01? PMID: 37661178. Review˰ ˍ

Serritella AV, Shenoy NK.
Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis.
JAMA Oncol. 2023 Aug 31:e233295
. doi: 10.1001/jamaoncol.2023.3295. PMID: 37651124. Meta-analysis. ˍ

Tinnirello R, Chinnici CM, Miceli V, Busà R, Bulati M, Gallo A, Zito G, Conaldi PG, Iannolo G.
Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment.
Int J Mol Sci. 2023 Aug 31;24(17):13550
. doi: 10.3390/ijms241713550. PMID: 37686355. Review. ˍ